C4 Therapeutics, Inc. · NASDAQ:CCCC
BlackRock, Inc.'s stake in C4 Therapeutics, Inc. fell to 2.50% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 16, 2025
BlackRock, Inc.'s stake in C4 Therapeutics, Inc. fell to 2.50%, 1,756,613 shares, as a passive investor on Jun 30, 2025. Filed Jul 16, 2025 (Schedule 13G/A).
- Stake
- 2.50%
- Shares
- 1,756,613
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 2.50% | 1,756,613 |
Source
Related
- C4 Therapeutics, Inc.
- BlackRock, Inc.
- C4 Therapeutics, Inc. shareholders
- Schedule 13G · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Anderson Kenneth Carl · Oct 2, 2026
- Form 4 · Grogan Donna Roy · Oct 2, 2026
- Form 4 · Adams Kendra · Sep 21, 2026
- Schedule 13G/A · Lynx1 Capital Management LP · Aug 14, 2026
- Schedule 13G/A · Squadron Capital Management LLC · Aug 14, 2026